Evidence map›Paper›PMID 33060722›Full record

ArticleScientific reports2020

A C-peptide complex with albumin and Zn

M Geiger, T Janes, H Keshavarz, S Summers, C Pinger, D Fletcher, K Zinn, M Tennakoon, A Karunarathne, D Spence

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. UPLC-MS/MS method for quantitative determination of the advanced glycation endproductsAnalytical methods : advancing methods and applications · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

M GeigerDepartment of Chemistry, Michigan State University, East Lansing, MI, 48824, USA.
T JanesDepartment of Chemistry, Michigan State University, East Lansing, MI, 48824, USA.
H KeshavarzDepartment of Chemistry, Michigan State University, East Lansing, MI, 48824, USA.
S SummersDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI, 48824, USA.
C PingerDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI, 48824, USA.
D FletcherSparrow Hospital, East Lansing, MI, 48823, USA.
K ZinnDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI, 48824, USA.
M TennakoonDepartment of Chemistry and Biochemistry, The University of Toledo, Toledo, OH, 43606, USA.
A KarunarathneDepartment of Chemistry and Biochemistry, The University of Toledo, Toledo, OH, 43606, USA.
D SpenceDepartment of Biomedical Engineering, Michigan State University, East Lansing, MI, 48824, USA. spenceda@msu.edu.
Michigan State University · USUniversity of Toledo · USSparrow Hospital · US

Funding

A Novel Fluidic and Membrane-based Platform for Inhibiting Intercellular CommunicationR01DK110665 · NIDDK · MICHIGAN STATE UNIVERSITY · PI SPENCE, DANA M · 2016 to 2019
$1.6M
NIDDK NIH HHS R01 DK110665
6 · The paper itself

Abstract

People with type 1 diabetes (T1D) require exogenous administration of insulin, which stimulates the translocation of the GLUT4 glucose transporter to cell membranes. However, most bloodstream cells contain GLUT1 and are not directly affected by insulin. Here, we report that C-peptide, the 31-amino acid peptide secreted in equal amounts with insulin in vivo, is part of a 3-component complex that affects red blood cell (RBC) membranes. Multiple techniques were used to demonstrate saturable and specific C-peptide binding to RBCs when delivered as part of a complex with albumin. Importantly, when the complex also included Zn

Indexed as

Adenosine TriphosphateAnimalsBiological TransportCattleCell MembraneC-PeptideDiabetes Mellitus, Type 1ErythrocytesGene Expression RegulationGlucoseGlucose Transporter Type 1HumansInsulinSerum Albumin, BovineZincAdenosine TriphosphateC-PeptideGlucoseGlucose Transporter Type 1InsulinSerum Albumin, BovineSLC2A1 protein, humanZinc

Identifiers

PMID33060722
PMCPMC7566639
OpenAlexW3093268194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.